Premenstrual syndrome and quality of life of woman. Effectiveness of herbal drugs
DOI:
https://doi.org/10.18370/2309-4117.2018.39.76-80Keywords:
рremenstrual syndrome, PMS, quality of life, virgin bush, Vitex Agnus-castus, Mastodynon, CyclodinonAbstract
The premenstrual syndrome (PMS) is a pathological symptom that significantly reduces the quality of a woman’s life. The etiology and pathogenesis to date have not been sufficiently studied, but the diagnosis, treatment and prevention that are to be complied with have been identified. The treatment of the PMS should be differentiated, taking into account the overall and reproductive health of the woman, the concomitant diseases, the degree of severity of ICP, the portability of therapy, etc.
References
- Prilepskaya, V.N., Ledina, A.V., Tagiyeva, A.V., Revazova, F.S. “Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome.” Maturitas 55 Suppl. 1 (2006): 55–63.
- Aganezova, N.V. “Premenstrual syndrome: biological and psychosocial predictors of pathogenesis, clinic, rationale for complex therapy.” Thesis for MD degree. St. Petersburg (2011): 372 p.
- Ledina, A.V. “Premenstrual syndrome: epidemiology, clinical picture, diagnosis and treatment.” Thesis abstract for MD degree. Moscow (2014).
- Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome. Green-top Guideline No. 48. BJOG (2016). DOI: 10.1111/1471-0528.14260
- Zamani, M., Neghab, N., Torabian, S. “Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.” Acta MedIran 50 (2012): 101–6.
- Prilepskaya, V.N., Mezhevitinova, E.A., Sasunova, R.A., et al. “Results of clinical use of a drug containing drospirenone in women with severe premenstrual syndrome.” Obstetrics and gynecology 2 (2012): 81–5.
- Rafieian-Kopaei, M., Movahedi, M. “Systematic Review of Premenstrual, Postmenstrual and Infertility Disorders of Vitex Agnus Castus.” Electronic Physician 9.1 (2017): 3685–9.
- Sarrafchi, A., Bahmani, M., Shirzad, H., Rafieian-Kopaei, M. “Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants.” Curr Pharm Des 22.2 (2016): 238–46.
- Miraj, S., Rafieian-Kopaei, M., Kiani, S. “Melissa officinalis L: A Review Study With an Antioxidant Prospective.” J Evid Based Complementary Altern Med, 2016. DOI: 10.1177/2156587216663433
- Baharvand-Ahmadi, B., Bahmani, M., Tajeddini, P., et al. “An ethnobotanical study of medicinal plants administered for the treatment of hypertension.” J Renal Inj Prev 5.3 (2016): 123–8. DOI: 10.15171/jrip.2016.26
- Rouhi-Boroujeni, H., Gharipour, M., Mohammadizadeh, F., et al. “Systematic review on safety and drug interaction of herbal therapy in hyperlipidemia: a guide for internist.” Acta Biomed 86.2 (2015): 130–6.
- Khalilzadeh, E., Vafaei Saiah, G., Hasannejad, H., et al. “Antinociceptive effects, acute toxicity and chemical composition of Vitex agnus-castus essential oil.” Avicenna J Phytomed 5.3 (2015): 218–30.
- He, Z., Chen, R., Zhou, Y., et al. “Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multicenter placebo controlled study in China.” Maturitas 63.1 (2009): 99–103. DOI: 10.1016/j.maturitas.2009.01.006
- Jang, S.H., Kim, D.I., Choi, M.S. “Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review.” BMC Complement Altern Med 14 (2014): 11. DOI: 10.1186/1472-6882-14-11
- Weisz, G., Knaapen, L. “Diagnosing and treating premenstrual syndrome in five western nations.” Soc Sci Med 68.8 (2009): 1498–505. DOI: 10.1016/j.socscimed.2009.01.036
- Atmaca, M., Kumru, S., Tezcan, E. “Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.” Hum Psychopharmacol 18.3 (2003): 191–5. DOI: 10.1002/hup.470
- Ma, L., Lin, S., Chen, R., et al. “Evaluating therapeutic effect in symptoms of moderate - to - severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.” Aust N Z J Obstet Gynaecol 50.2 (2010): 189–93. DOI: 10.1111/j.1479-828X.2010.01137.x
- Kelderhouse, K., Taylor, J.S. “A review of treatment and management modalities for premenstrual dysphoric disorder.” Nurs Womens Health 17.4 (2013): 294–305. DOI: 10.1111/1751-486X.12048
- Dietz, B.M., et al. “Botanicals and Their Bioactive Phytochemicals for Women’s Health.” Pharmacol Rev 68.4 (2016): 1026–73.
- Rafieian-Kopaei, M., Saki, K., Bahmani, M., et al. “Listeriosis Phytotherapy: A Review Study on the Effectiveness of Iranian Medicinal Plants in Treatment of Listeriosis.” J Evid Based Complementary Altern Med (2015). DOI: 10.1177/2156587215621460
- van Die, M.D., Burger, H.G., Teede, H.J., Bone, K.M. “Vitex agnus-castus Extracts for Female Reproductive Disorders: A Systematic Review of Clinical Trials.” Women’s Health. Planta Med 79.07 (2013): 562–75.
- Bahmani, M., Sarrafchi, A., Shirzad, H., Rafieian-Kopaei, M. “Autism: Pathophysiology and Promising Herbal Remedies.” Curr Pharm Des 22.3 (2016): 277–85. DOI: 10.2174/1381612822666151112151529
- Ambrosini, A., Di Lorenzo, C., Coppola, G., Pierelli, F. “Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation.” Acta Neurol Psychiatr Belg 113.1 (2013): 25–9. DOI: 10.1007/s13760-012-0111-4
- Webster, D.E., He, Y., Chen, S.N., et al. “Opioidergic mechanisms underlying the actions of Vitex agnus-castus L.” Biochem pharmacol 81.1 (2011): 170–7. DOI: 10.1016/j.bcp.2010.09.013
- van Die, M.D., Bone, K.M., Burger, H.G., et al. “Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis.” J Altern Complement Med 15.9 (2009): 1045–8. DOI: 10.1089/acm.2008.0539
- Royal College of Obstetricians and Gynaecologists. NAPS Guidelines on Guidelines on Premenstrual Syndrom, 01.12.2016.
- Marjoribanks, J., Brown, J., O’Brien, P.M., Wyatt, K. “Selective serotonin reuptake inhibitors for premenstrual syndrome.” Cochrane Database Syst Rev 6 (2013): CD001396. DOI: 10.1002/14651858.CD001396.pub3
- Upchurch, D.M., Chyu, L., Greendale, G.A., et al. “Complementary and alternative medicine use among American women: findings from The National Health Interview Survey, 2002.” J Women’s Health (Larchmt) 16 (2007): 102–13.
- Zamani, M., Neghab, N., Torabian, S. “Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.” Acta Med Iran 50.2 (2012): 101–6.
- Ledina, A.V., Prilepskaya, V.N. “Drospirenone-Contraceptive: Therapeutic and Prophylactic Aspects of Use.” Gynecology 17.1 (2015): 25–9.
- Lauritzen, C., Reuter, H.D., Repges, R., et al. “Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, doubleblind study versus pyridoxine.” Phytomedicine 4.3 (1997): 183–9. DOI: 10.1016/S0944-7113(97)80066-9
- Andrade, C. “Premenstrual dysphoric disorder: General overview, treatment strategies, and focus on sertraline for symptom-onset dosing.” Indian J Psychiatry 58.3 (2016): 329–31. DOI: 10.4103/0019-5545.192014
- Ryu, A., Kim, T.H. “Premenstrual syndrome: A mini review.” Maturitas 82.4 (2015): 436–40. DOI: 10.1016/j.maturitas.2015.08.010
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 В. Н. Прилепская, Э. Р. Довлетханова
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.